Tenet Healthcare Corporation (THC)
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tenet Healthcare (THC) Advances But Underperforms Market: Key Facts
In the most recent trading session, Tenet Healthcare (THC) closed at $129.64, indicating a +0.14% shift from the previous trading day.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare: Walk-In Surgical Care Facilities Are A Key Revenue Driver
Tenet Healthcare is well-positioned for long-term growth due to rising healthcare demand and strategic focus on cost-efficient outpatient services. Financials show strong revenue and net income growth, driven by asset sales, higher operating income, and expense management. Ambulatory Surgery Centers are set for continued revenue growth and are likely to be a key driver of Tenet's continues success.
Tenet Healthcare downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Jamie Perse downgraded Tenet Healthcare to Neutral from Buy with a price target of $140, down from $196. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. For Tenet, the analyst sees policy risk "taking center stage" and likely leaving shares range bound until policy outcomes are better defined, reflected in out year estimates, and in the stock's valuation.
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
After Plunging -16.78% in 4 Weeks, Here's Why the Trend Might Reverse for Tenet (THC)
The heavy selling pressure might have exhausted for Tenet (THC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Wall Street Analysts Look Bullish on Tenet (THC): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Tenet (THC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Tenet (THC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Tenet (THC). This makes it worthwhile to examine what the stock has in store.
Why Now is the Time to Buy Tenet Stock After a 15% Drop
THC's cheaper valuation, combined with strong earnings growth and robust free cash flow, makes it an appealing pick for value investors.
